SurgePays (SURG) Projected to Post Quarterly Earnings on Tuesday

Key Points

• SurgePays (NASDAQ:SURG) is set to announce its Q2 2025 earnings on August 12th, with analysts predicting a loss of $0.31 per share and revenues of $16.14 million.
• The company recently reported a Q1 loss of $0.38 per share, slightly surpassing analysts' expectations, along with revenues of $10.58 million, which also beat consensus estimates.
• Despite trading down 2.7% to $2.63, SurgePays has seen ratings upgrades from analysts, with Ascendiant Capital Markets raising their price target to $9.00 and changing their rating to "buy."

SurgePays (NASDAQ:SURG - Get Free Report) is expected to be announcing its Q2 2025 earnings results after the market closes on Tuesday, August 12th. Analysts expect the company to announce earnings of ($0.31) per share and revenue of $16.14 million for the quarter.

SurgePays (NASDAQ:SURG - Get Free Report) last issued its earnings results on Tuesday, May 13th. The medical equipment provider reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.40) by $0.02. The company had revenue of $10.58 million during the quarter, compared to the consensus estimate of $9.80 million. SurgePays had a negative return on equity of 206.01% and a negative net margin of 136.37%. During the same period last year, the business posted $0.07 EPS. On average, analysts expect SurgePays to post $-2 EPS for the current fiscal year and $0 EPS for the next fiscal year.

SurgePays Trading Up 2.0%

NASDAQ SURG opened at $2.99 on Thursday. SurgePays has a 52 week low of $1.05 and a 52 week high of $3.47. The business has a 50 day moving average price of $2.93 and a 200-day moving average price of $2.33. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.24. The company has a market cap of $61.03 million, a price-to-earnings ratio of -1.07 and a beta of 0.44.

Institutional Trading of SurgePays

An institutional investor recently bought a new position in SurgePays stock. Goldman Sachs Group Inc. purchased a new position in shares of SurgePays, Inc. (NASDAQ:SURG - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 13,456 shares of the medical equipment provider's stock, valued at approximately $28,000. Goldman Sachs Group Inc. owned about 0.07% of SurgePays as of its most recent SEC filing. 6.94% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on SURG shares. Ascendiant Capital Markets increased their price objective on SurgePays from $8.75 to $9.00 and gave the stock a "buy" rating in a research note on Monday, June 16th. Wall Street Zen raised SurgePays from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd.

SurgePays Company Profile

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.